| Pharmaceutical Information |
| Drug Name |
Cyclizine |
| Drug ID |
BADD_D00543 |
| Description |
A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935) |
| Indications and Usage |
For prevention and treatment of nausea, vomiting, and dizziness associated with motion sickness, and vertigo (dizziness caused by other medical problems). |
| Marketing Status |
approved |
| ATC Code |
R06AE03 |
| DrugBank ID |
DB01176
|
| KEGG ID |
D03621
|
| MeSH ID |
D003501
|
| PubChem ID |
6726
|
| TTD Drug ID |
D08HRJ
|
| NDC Product Code |
Not Available |
| UNII |
QRW9FCR9P2
|
| Synonyms |
Cyclizine | Marezine | Cyclizine Hydrochloride | Hydrochloride, Cyclizine | Cyclizine HCl | HCl, Cyclizine |
|
| Chemical Information |
| Molecular Formula |
C18H22N2 |
| CAS Registry Number |
82-92-8 |
| SMILES |
CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
